(Q40777644)

23 September 2017

Specific interactions of monotetrahydrofuranic annonaceous acetogenins as inhibitors of mitochondrial complex I. (English)

1 reference

23 September 2017

1 reference

1 reference

1 reference

1 reference

1 reference

1 reference

1 reference

1

1 reference

23 September 2017

Gallardo T

2

1 reference

23 September 2017

Aragón R

series ordinal

3

1 reference

23 September 2017

Cortes D

series ordinal

4

1 reference

23 September 2017

Estornell E

series ordinal

5

1 reference

23 September 2017

1 November 1999

1 reference

Chemico-biological Interactions

23 September 2017

1 reference

23 September 2017

122

1 reference

23 September 2017

171-183

1 reference

23 September 2017

3

1 reference

Acetogenins from Annonaceae, inhibitors of mitochondrial complex I.

23 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0009-2797%2899%2900120-9

Natural acetogenins from annonaceae, synthesis and mechanisms of action

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-2797%2899%2900120-9

Molecular mode of action of annonins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-2797%2899%2900120-9

Natural substances (acetogenins) from the family Annonaceae are powerful inhibitors of mitochondrial NADH dehydrogenase (Complex I)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-2797%2899%2900120-9

Mode of action of bullatacin, a potent antitumor acetogenin: inhibition of NADH oxidase activity of HeLa and HL-60, but not liver, plasma membranes.

7 January 2021

2 references

https://api.crossref.org/works/10.1016%2FS0009-2797%2899%2900120-9

7 January 2021

https://api.crossref.org/works/10.1016%2FS0009-2797%2899%2900120-9

inferred from DOI database lookup

7 January 2021

based on heuristic

Tumor cell growth inhibition by several Annonaceous acetogenins in an in vitro disk diffusion assay.

1 reference

https://api.crossref.org/works/10.1016%2FS0009-2797%2899%2900120-9

Structure-activity relationships of diverse Annonaceous acetogenins against multidrug resistant human mammary adenocarcinoma (MCF-7/Adr) cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-2797%2899%2900120-9

Determination of structure-activity relationships of Annonaceous acetogenins by inhibition of oxygen uptake in rat liver mitochondria

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-2797%2899%2900120-9

SARs of annonaceous acetogenins in rat liver mitochondria

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-2797%2899%2900120-9

Essential structural factors of annonaceous acetogenins as potent inhibitors of mitochondrial complex I

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-2797%2899%2900120-9

Rollimembrin, a novel acetogenin inhibitor of mammalian mitochondrial complex I

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-2797%2899%2900120-9

10-Oximeguanacone, the first nitrogenated acetogenin derivative found to be a potent inhibitor of mitochondrial complex I

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-2797%2899%2900120-9

Acetogenins from Annona glabra seeds

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-2797%2899%2900120-9

Two binding sites of inhibitors in NADH: ubiquinone oxidoreductase (complex I). Relationship of one site with the ubiquinone-binding site of bacterial glucose:ubiquinone oxidoreductase.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-2797%2899%2900120-9

Cherimolin-1, new selective inhibitor of the first energy-coupling site of the NADH: ubiquinone oxidoreductase (complex I).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-2797%2899%2900120-9

Inhibitors of NADH-ubiquinone reductase: an overview

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-2797%2899%2900120-9

Structure-activity relationships of some complex I inhibitors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-2797%2899%2900120-9

Complex I and complex III of mitochondria have common inhibitors acting as ubiquinone antagonists

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-2797%2899%2900120-9

Steady-state kinetics of the reduction of coenzyme Q analogs by complex I (NADH:ubiquinone oxidoreductase) in bovine heart mitochondria and submitochondrial particles.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-2797%2899%2900120-9

Assay conditions for the mitochondrial NADH:coenzyme Q oxidoreductase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-2797%2899%2900120-9

Quinone specificity of complex I

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-2797%2899%2900120-9

The specificity of mitochondrial complex I for ubiquinones

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-2797%2899%2900120-9

Specificity of pyridinium inhibitors of the ubiquinone reduction sites in mitochondrial complex I

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-2797%2899%2900120-9

Qualitative and quantitative evaluation of annonaceous acetogenins by high performance liquid chromatography

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-2797%2899%2900120-9

The mechanism of proton and electron transport in mitochondrial complex I.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-2797%2899%2900120-9

Proton-translocation by membrane-bound NADH:ubiquinone-oxidoreductase (complex I) through redox-gated ligand conduction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-2797%2899%2900120-9

A reductant-induced oxidation mechanism for complex I

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-2797%2899%2900120-9

Enantiospecific semisynthesis of (+)-almuheptolide-A, a novel natural heptolide inhibitor of the mammalian mitochondrial respiratory chain.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-2797%2899%2900120-9

Three classes of inhibitors share a common binding domain in mitochondrial complex I (NADH:ubiquinone oxidoreductase).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-2797%2899%2900120-9

Structural factors of rotenone required for inhibition of various NADH-ubiquinone oxidoreductases.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-2797%2899%2900120-9

Membrane conformations and their relation to cytotoxicity of asimicin and its analogues

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-2797%2899%2900120-9

10.1016/S0009-2797(99)00120-9

7 January 2021

Identifiers

DOI

1 reference

23 September 2017

1 reference